Retinoic acid and its derivatives, collectively known as retinoids, are used to treat several skin conditions like acne and photoaging by promoting skin cell turnover and collagen production. They are also used in cancer treatment, most notably to treat acute promyelocytic leukemia (APL) and are being studied for their role in preventing and treating other cancers by influencing cancer cell growth and behavior. It is grouped under the following drug class(es): Keratolytics, Retinoids and Vitamins. Its therapeutic use is listed as acne agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include tretinoin, ATRA, Renova, Aberel, Eudyna and Atralin. It is also listed for alternate use as: API Intermediate. Its PubChem CID is 444795.
Retinoic acid
| CAS No | 302-79-4 |
|---|---|
| Molecular Formula | C20H28O2 |
| Molecular Weight | 300.4 g/mol |
| Synonyms | (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Retinoic acid and its derivatives, collectively known as retinoids, are used to treat several skin conditions like acne and photoaging by promoting skin cell turnover and collagen production.
The listed CAS number is 302-79-4.
The listed molecular formula is C20H28O2.
The listed molecular weight is 300.4 g/mol.
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid.
The source lists tretinoin, ATRA, Renova, Aberel, Eudyna and Atralin.